Omeprazole before Endoscopy in Patients with Gastrointestinal Bleeding
Open Access
- 19 April 2007
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 356 (16), 1631-1640
- https://doi.org/10.1056/nejmoa065703
Abstract
A neutral gastric pH is critical for the stability of clots over bleeding arteries. We investigated the effect of preemptive infusion of omeprazole before endoscopy on the need for endoscopic therapy. Consecutive patients admitted with upper gastrointestinal bleeding underwent stabilization and were then randomly assigned to receive either omeprazole or placebo (each as an 80-mg intravenous bolus followed by an 8-mg infusion per hour) before endoscopy the next morning. Over a 17-month period, 638 patients were enrolled and randomly assigned to omeprazole or placebo (319 in each group). The need for endoscopic treatment was lower in the omeprazole group than in the placebo group (60 of the 314 patients included in the analysis [19.1%] vs. 90 of 317 patients [28.4%], P=0.007). There were no significant differences between the omeprazole group and the placebo group in the mean amount of blood transfused (1.54 and 1.88 units, respectively; P=0.12) or the number of patients who had recurrent bleeding (11 and 8, P=0.49), who underwent emergency surgery (3 and 4, P=1.00), or who died within 30 days (8 and 7, P=0.78). The hospital stay was less than 3 days in 60.5% of patients in the omeprazole group, as compared with 49.2% in the placebo group (P=0.005). On endoscopy, fewer patients in the omeprazole group had actively bleeding ulcers (12 of 187, vs. 28 of 190 in the placebo group; P=0.01) and more omeprazole-treated patients had ulcers with clean bases (120 vs. 90, P=0.001). Infusion of high-dose omeprazole before endoscopy accelerated the resolution of signs of bleeding in ulcers and reduced the need for endoscopic therapy. (ClinicalTrials.gov number, NCT00164866.)Keywords
This publication has 12 references indexed in Scilit:
- Meta‐analysis: proton‐pump inhibition in high‐risk patients with acute peptic ulcer bleedingAlimentary Pharmacology & Therapeutics, 2005
- Deoxycholic acid activates protein kinase C and phospholipase C via increased Ca2+ entry at plasma membraneGastroenterology, 2005
- Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.Canadian Journal of Gastroenterology, 2004
- Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal BleedingAnnals of Internal Medicine, 2003
- Author indexGut, 2002
- Effect of Intravenous Omeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic UlcersThe New England Journal of Medicine, 2000
- A Comparison of Omeprazole and Placebo for Bleeding Peptic UlcerThe New England Journal of Medicine, 1997
- Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United KingdomBMJ, 1995
- Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.BMJ, 1992
- Statistics in Medicine: Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and ratesBMJ, 1988